Key result
A multimodal imaging approach combining CCT, CMR, PET, and SPECT locates and functionally characterizes cardiac paragangliomas, aiding in diagnosis, monitoring, and treatment planning.
Why the study?
A multimodal imaging approach to cardiac paragangliomas is not yet standardized, prompting an investigation into the roles of CCT, CMR, PET, and SPECT in diagnosis, characterization, and monitoring.
What is the role of advanced diagnostic imaging (CCT, CMR, PET, SPECT) in the diagnosis, characterization, and monitoring of cardiac paragangliomas?
Systematic Review
What is the role of advanced diagnostic imaging (CCT, CMR, PET, SPECT) in the diagnosis, characterization, and monitoring of cardiac paragangliomas?
A multimodal imaging approach combining CCT, CMR, PET, and SPECT is useful for the diagnosis, characterization, and monitoring of rare cardiac paragangliomas.
Answers are grounded in this paper and cite their sources.
Supports multimodal imaging for cardiac paraganglioma diagnosis and monitoring; extends synthesized evidence for rare tumors.
• PGLs are rare tumors explored by different imaging modalities. • Advanced morphological and functional imaging would allow characterization and monitoring of the lesion. • Multimodal morphological imaging approach obtained with CCT and CMR, combined with PET and SPECT, locates and functionally characterizes cardiac PGL. Cardiac ParaGangliomas (PGLs) are rare extra-adrenal tumours that arise from chromaffin cells of the sympathetic ganglia. PGL are often diagnosed incidentally, with no symptoms or symptoms related to cardiovascular dysfunction. Cardiac Computed Tomography (CCT) and Cardiac Magnetic Resonance (CMR) can detect the correct morphology and position of the lesion and provide proper tissue characterization. Nuclear medicine imaging, with Positron Emission Tomography (PET) or Single Photon Emission Computed Tomography (SPECT) with specific radiotracers, can evaluate the functionality of the PGL and to distinguish a secreting from a non-secreting tumour. In association with biochemical parameters, a multimodal imaging approach, not yet standardized, can be useful both in the diagnosis, in the monitoring and in the treatment planning. In this systematic review, we aim to investigate the role of diagnostic imaging, in particular CCT, CMR, PET and SPECT in diagnosis, characterization and monitoring of cardiac PGLs.
No takes yet. Share an insight, caveat, or question.
Punzo et al. (2024) conducted a systematic review in Cardiac Paraganglioma. Advanced diagnostic imaging (CCT, CMR, PET, SPECT) was evaluated on Diagnosis, characterization, and monitoring of cardiac PGLs. A multimodal imaging approach combining CCT, CMR, PET, and SPECT locates and functionally characterizes cardiac paragangliomas, aiding in diagnosis, monitoring, and treatment planning.
Synapse has enriched 10 related papers. Consider them for comparative context: